Background: The outbreak of the coronavirus disease 2019 (COVID-19) has had profound impact on health care not only for its direct effects, but also because it deeply influenced the whole clinical practice and diagnostic pathways, particularly in the acute setting. Case report: We present the case of a patient with respiratory dysfunction due to myasthenia gravis (MG) initially misdiagnosed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to ambiguity in the interpretation of radiological and microbiological findings during COVID-19 pandemic. Discussion: Respiratory dysfunction as first clinical manifestation of myasthenia gravis is rare, but potentially very harmful. Emergency physicians should always consider neurological diseases when dyspnea cannot be explained by cardiac or respiratory causes.

Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19 / G. Scopelliti, M. Osio, M. Arquati, L. Pantoni. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 41:12(2020 Dec), pp. 3419-3421. [10.1007/s10072-020-04826-3]

Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19

G. Scopelliti
Primo
;
L. Pantoni
Ultimo
2020

Abstract

Background: The outbreak of the coronavirus disease 2019 (COVID-19) has had profound impact on health care not only for its direct effects, but also because it deeply influenced the whole clinical practice and diagnostic pathways, particularly in the acute setting. Case report: We present the case of a patient with respiratory dysfunction due to myasthenia gravis (MG) initially misdiagnosed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to ambiguity in the interpretation of radiological and microbiological findings during COVID-19 pandemic. Discussion: Respiratory dysfunction as first clinical manifestation of myasthenia gravis is rare, but potentially very harmful. Emergency physicians should always consider neurological diseases when dyspnea cannot be explained by cardiac or respiratory causes.
COVID-19; Dyspnea; Emergency medicine; Myasthenia gravis; SARS-CoV-2
Settore MED/26 - Neurologia
dic-2020
17-ott-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Scopelliti Neurol Sci 2020_Myastenia & COVID_FINAL.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 649.94 kB
Formato Adobe PDF
649.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/787031
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact